Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Beam Therapeutics Inc.

Initiate IND-enabling studies for BEAM-102

Delivered after the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
12 Jan 2021
Due
31 Dec 2021
Delivered
November 2022
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“Initiate IND-enabling studies for BEAM-102”

What we found

Evidence strength A What the grades mean

The company announced in November 2022 that it had initiated IND-enabling studies for BEAM-301, meeting the 2022 deadline.

  • A
    Beam Therapeutics Inc. 10-K filed 2023-02-28 Regulatory filing · published 28 Feb 2023 · retrieved 2 Oct 2026 · kept permanently by the SEC · fingerprint 7d449214f52a
    “In November 2022, we announced that we had initiated IND-enabling studies for BEAM-301.” ✓ confirmed on the page

Checked 2 Oct 2026.

Commitment lineage

Every time the company restated this commitment. The original is never changed, and the outcome is always measured against version 1.

  • Deadline drift +365 days
  • 2 versions
  1. Version 1 · original · stated 12 Jan 2021

    Deadline 31 Dec 2021 (“in 2021”)

  2. Version 2 · stated 10 Jan 2022

    Deadline 31 Dec 2022 (“2022”)

    “Initiate IND-enabling studies for BEAM-301”

    Source for this version

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical milestone
Indicative materiality
Medium rules
Action
Initiate
Deliverable
IND-enabling studies for BEAM-102
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “no_evidence”.
  4. Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Beam Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-BEAM-021939 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.